Phase III randomized trial comparing moderate-dose cisplatin to combined cisplatin and carboplatin in addition to mitomycin and ifosfamide in patients with stage IV non-small-cell lung cancer.
about
Lung cancer--where are we today? Current advances in staging and nonsurgical treatment.Chemotherapy of lung cancer: A global perspective of the role of ifosfamideFactors affecting efficacy and safety of add-on combination chemotherapy for non-small-cell lung cancer: a literature-based pooled analysis of randomized controlled trials.
P2860
Phase III randomized trial comparing moderate-dose cisplatin to combined cisplatin and carboplatin in addition to mitomycin and ifosfamide in patients with stage IV non-small-cell lung cancer.
description
2000 nî lūn-bûn
@nan
2000 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
Phase III randomized trial com ...... IV non-small-cell lung cancer.
@ast
Phase III randomized trial com ...... IV non-small-cell lung cancer.
@en
Phase III randomized trial com ...... IV non-small-cell lung cancer.
@nl
type
label
Phase III randomized trial com ...... IV non-small-cell lung cancer.
@ast
Phase III randomized trial com ...... IV non-small-cell lung cancer.
@en
Phase III randomized trial com ...... IV non-small-cell lung cancer.
@nl
prefLabel
Phase III randomized trial com ...... IV non-small-cell lung cancer.
@ast
Phase III randomized trial com ...... IV non-small-cell lung cancer.
@en
Phase III randomized trial com ...... IV non-small-cell lung cancer.
@nl
P2093
P2860
P356
P1476
Phase III randomized trial com ...... IV non-small-cell lung cancer.
@en
P2093
Alexopoulos CG
Berghmans T
Klastersky J
Koumakis G
Lafitte JJ
Paesmans M
P2860
P2888
P304
P356
10.1054/BJOC.2000.1413
P407
P577
2000-11-01T00:00:00Z
P5875
P6179
1008948063